Methods for treatment of bile acid-related disorders
AssigneeNGM Biopharmaceuticals, Inc.
InventorsLei Ling, Jian Luo, Hui Tian
Life of this patent
Estimating the term…
Loading patent…
AssigneeNGM Biopharmaceuticals, Inc.
InventorsLei Ling, Jian Luo, Hui Tian
Estimating the term…
Provided herein are variants of fibroblast growth factor 19 (FGF19) proteins and peptide sequences (and peptidomimetics) and fusions of FGF19 and/or fibroblast growth factor 21 (FGF21) proteins and peptide sequences (and peptidomimetics), and variants of fusions of FGF19 and/or FGF21 proteins and peptide sequences (and peptidomimetics). In some embodiments, these variants and fusions modulate bile acid homeostasis, and are useful in treatment of bile acid related and associated disorders. In some embodiments, these variants and fusions have glucose lowering activity, and are useful in treatment of hyperglycemia and other disorders.
-76. (canceled)
A method of preventing the induction or exacerbation of pruritus associated with non-alcoholic steatohepatitis (NASH) in a subject being treated for NASH, comprising administering to the subject an effective amount of a peptide, wherein the peptide comprises:
Dependencies are inferred from the claim text.